Hi RED,
I found it interesting when reading the Japanese patent approval that the mode of activity of RCE 327 & 529 are as stated:
"Use of R327 or R529 for the treatment of viruses having a lipid envelope or coat, examples being SARS-CoV-2 and corona viruses, influenza viruses, HIV, hepatitis, Ross River and Herpes viruses".
Therefore one might assume that RCE is a lipopeptide material - maybe someone else with a more bio-chemical nouse can answer this for us...
Rgds
DW
Hi RED,I found it interesting when reading the Japanese patent...
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
56.5¢ |
Change
-0.005(0.88%) |
Mkt cap ! $115.2M | |||
| Open | High | Low | Value | Volume |
| 57.0¢ | 57.0¢ | 56.0¢ | $24.17K | 42.92K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 5551 | 56.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 57.0¢ | 47240 | 1 |
View Market Depth
| Last trade - 15.40pm 07/06/2024 (20 minute delay) ? |
|
|||||
|
Last
56.5¢ |
Change
-0.005 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 56.5¢ | 56.5¢ | 56.5¢ | 1 | ||
| Last updated 15.43pm 07/06/2024 ? | |||||
| RCE (ASX) Chart |